Molecular Formula | C7H11NO4 |
Molar Mass | 173.17 |
Density | 1.3346 (rough estimate) |
Melting Point | 132-133°C (dec.)(lit.) |
Boling Point | 303.8°C (rough estimate) |
Specific Rotation(α) | -119 º (c=4 in H2O) |
Vapor Presure | 0Pa at 20℃ |
Appearance | Crystalline Powder |
Color | White |
Merck | 14,6903 |
BRN | 84043 |
pKa | 3.48±0.40(Predicted) |
Storage Condition | Sealed in dry,2-8°C |
Refractive Index | 1.4490 (estimate) |
MDL | MFCD00037339 |
Use | This product is for scientific research only and shall not be used for other purposes. |
Hazard Symbols | Xi - Irritant |
Risk Codes | 41 - Risk of serious damage to eyes |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. |
WGK Germany | 3 |
FLUKA BRAND F CODES | 10 |
TSCA | Yes |
HS Code | 29339900 |
LogP | -1.51 at 20℃ |
EPA chemical substance information | information provided by: ofmpeb.epa.gov (external link) |
biological activity | Oxaceprol (N-acetyl-L-hydroxyproline) is an anti-inflammatory drug used to treat osteoarthritis. |
Animal Model: | Male Sprague-Dawley rats. |
Dosage: | 18, 50 or 150 mg/kg. |
Administration: | Gavage daily for 15 days. |
Result: | Produced comparable inhibition of hyperalgesia to that produced by indomethacin. |